Medical Discovery NewsBridging the World of Medical Discovery and You

Recent Episodes

Knocking Out Hepatitis C

MP3 WAV

Hepatitis C kills more people in the world than HIV and is the leading cause of liver transplants in the US. But that's about to change dramatically. A new drug may wipe out Hepatitis C infections with basically one pill a day for eight weeks and without severe side effects.

The current treatment is excruciating where side effects include terrible rashes, depression, and fever. It requires up to forty-eight weeks of ribaviron and interferon alpha. The interferon is what patients dread.

The new drugs, much like HIV medications, target enzymes the Hepatitis C virus requires to reproduce. But, unlike HIV where the virus' genetic information becomes part of someone's genetic makeup, the Hepatitis C virus does not do this. So, drugs can eliminate it and cure the patient. One of these new drugs is called sofosbuvir.

It inhibits the virus enzyme that copies its genetic information so that it can't reproduce. The drug is not paired with interferon injections for types two and three hepatitis C. But type one, which is what most Americans have, requires interferon although for a much shorter time.

Even better news is another pill called ledipasvir could eliminate the need for interferon and will soon be available. The public health benefit is tremendous. We'd see fewer liver transplants, liver cancer, and people dying from liver failure. The downside is the cost which could reach one hundred thousand dollars per treatment. Even so, they offer great promise.

Since Hepatitis C can lay latent for years, a number of baby boomers may be diagnosed in the coming years. So, don't wait. Get tested!

More Information

Hepatitis C
"Hepatitis C is a viral disease that leads to swelling (inflammation) of the liver."

Hepatitis C Information for the Public
"Hepatitis C is a liver disease that results from infection with the Hepatitis C virus. It can range in severity from a mild illness lasting a few weeks to a serious, lifelong illness."

Hepatitis C, a Silent Killer, Meets Its Match
"Determined to get rid of the hepatitis C infection that was slowly destroying his liver, Arthur Rubens tried one experimental treatment after another. None worked, and most brought side effects, like fever, insomnia, depression, anemia and a rash that 'felt like your skin was on fire.'"

 Medicine...

Medicine is constantly advancing – that is a great thing about life in the 21st century. But it doesn’t just happen. Dedicated biomedical scientists are making discoveries that translate into those new medical advances.

Biomedical science is broad, encompassing everything from social science to microbiology, biochemistry, epidemiology, to structural biology and bioinformatics to name just a few areas. And, it can involve basic fundamental biology, the use of AI and chemistry to clinical studies that evaluate new medicines in patients.

No matter the research focus, the goal is always the same, to advance human health. It may take a few months, a few years or for fundamental science, a few decades. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today on the medicine of tomorrow. Our weekly 500-word newspaper columns and 2-minute radio shows and podcasts provide insights into a broad range of biomedical science topics.

Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine.

Podcasts

Alternatively, you can copy and paste the following web address (URL) into iTunes as a new subscription:
https://www.medicaldiscoverynews.com/shows/audio/mdnews.rss

You can also search and subscribe to "Medical Discovery News" in the podcast section of iTunes.

See all podcasts and radio stations

The www.medicaldiscoverynews.com web site and Medical Discovery News radio program (Program) are made possible by The University of Texas Medical Branch at Galveston (UTMB)as a community service and are intended to advance UTMB's mission of providing scholarly teaching, innovative scientific investigation, and state-of-the-art patient care in a learning environment to better the health of society and its commitment to the discovery of new innovative biomedical and health services knowledge leading to increasingly effective and accessible health care for the citizens of Texas.

All information provided on the web site and in the Program is for informational purposes only and is not intended for use as diagnosis or treatment of a health problem or as a substitute for consulting a licensed medical professional. Any information obtained by participating as a web site visitor or program listener is not intended to and should not be considered to constitute medical advice.

Thoughts and opinions expressed on the Program or on the website are those of the authors or guests and do not necessarily reflect the opinions of UTMB. The provision of links to other websites is not to be construed as written or implied sponsorship or endorsement of such websites by UTMB.

Please contact Dr. David Niesel or Dr. Norbert Herzog via email with any concerns, suggestions or comments.

All rights are reserved to information provided on the website or other information sources. No part of these programs can be reproduced stored in a retrieval system or transcribed in any form or by any means for personal or financial gained without the express written permission of Drs. Niesel and Dr. Herzog.